Michel W. Wouters

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

Journal: Nature medicine

Published: July 10, 2025

The European Pediatric Surgical Audit: Improving Quality of Care in Rare Congenital Malformations.

The European Pediatric Surgical Audit: Improving Quality of Care in Rare Congenital Malformations.

Journal: European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie

Published: April 15, 2025

Improvement of perioperative outcomes of gastric gastrointestinal stromal tumour (GIST) resections and the influence of minimal invasive surgery.

Improvement of perioperative outcomes of gastric gastrointestinal stromal tumour (GIST) resections and the influence of minimal invasive surgery.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: April 08, 2024

Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma.

Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma.

Journal: JCI insight

Published: February 02, 2024

IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma.

IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma.

Journal: The Journal of experimental medicine

Published: November 14, 2022

Patterns of care over 10 years in young breast cancer patients in the Netherlands, a nationwide population-based study.

Patterns of care over 10 years in young breast cancer patients in the Netherlands, a nationwide population-based study.

Journal: Breast (Edinburgh, Scotland)

Published: September 22, 2022

Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial.

Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial.

Journal: Nature medicine

Published: April 11, 2022

Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma.

Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma.

Journal: JAMA surgery

Published: February 09, 2022

Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma.

Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma.

Journal: Annals of surgical oncology

Published: December 17, 2021

Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma.

Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 18, 2020

The use of FDG-PET/CT to detect early recurrence after resection of high-risk stage III melanoma.

The use of FDG-PET/CT to detect early recurrence after resection of high-risk stage III melanoma.

Journal: Journal of surgical oncology

Published: April 03, 2020

The Dutch Institute for Clinical Auditing: Achieving Codman's Dream on a Nationwide Basis.

The Dutch Institute for Clinical Auditing: Achieving Codman's Dream on a Nationwide Basis.

Journal: Annals of surgery

Published: January 24, 2020

Showing 1-12 of 34

Last Updated: 09/26/2026